MDFA 2022 research update
MDFA is committing to macular disease research
Faricimab has taken one step closer towards clinics in Australia.
The latest research relevant to optometrists and other health professionals
Participate in new intervention designed to improve glaucoma and diabetic eye care.
The US FDA recently approved two treatments: Susvimo® and Vabysmo®.
Volunteers with AMD sought to build a new computerised instrument.
Read the latest from CERA researchers Dr Zhichao Wu, Himeesh Kumar and Prof Robyn Guymer.
MDFA’s summary of the past 12 months’ research into macular disease.